SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-013675
Filing Date
2018-07-24
Accepted
2018-07-24 17:01:58
Documents
9
Period of Report
2018-07-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20180724_8k.htm 8-K 23037
2 EXHIBIT 10.1 ex_118431.htm EX-10.1 5097
3 EXHIBIT 10.2 ex_118432.htm EX-10.2 5073
4 EXHIBIT 10.3 ex_118433.htm EX-10.3 5211
5 EXHIBIT 99.1 ex_118434.htm EX-99.1 15773
6 img3.jpg GRAPHIC 5238
7 img2.jpg GRAPHIC 1831
8 img1.jpg GRAPHIC 6813
9 windtree.jpg GRAPHIC 9074
  Complete submission text file 0001437749-18-013675.txt   87828
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26422 | Film No.: 18967004
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1